Situation
Following Philips’ acquisition of Stellarex, the product needed a seamless transition into the Philips brand while maintaining its strong market presence. Additionally, ongoing data analysis and competitive positioning were crucial to establishing Stellarex as the leader in the peripheral drug-coated balloon (DCB) space.
Solution
A comprehensive rebranding effort was executed to align Stellarex with Philips' visual identity, messaging, and market positioning. Simultaneously, extensive data assessments and competitive analysis were conducted to highlight the product’s clinical superiority. Strategic marketing materials and campaigns were developed to reinforce Stellarex’s leadership in the peripheral DCB market.
Results
The successful rebranding strengthened Stellarex’s position within Philips' portfolio, enhancing credibility and market recognition. Competitive messaging and data-driven campaigns solidified Stellarex’s reputation as a category leader, driving increased awareness, provider confidence, and market share growth.